Establishment and characterization of a DOT1L inhibitor-sensitive human acute monocytic leukemia cell line YBT-5 with a novel KMT2A-MLLT3 fusion. [electronic resource]
Producer: 20200113Description: 617-625 p. digitalISSN:- 1099-1069
- Animals
- Antineoplastic Agents -- pharmacology
- Biomarkers
- Bone Marrow Cells
- Cell Line, Tumor
- Disease Models, Animal
- Drug Resistance, Neoplasm -- genetics
- Histone-Lysine N-Methyltransferase -- antagonists & inhibitors
- Humans
- Immunophenotyping
- In Situ Hybridization, Fluorescence
- Karyotyping
- Leukemia, Monocytic, Acute -- drug therapy
- Male
- Mice
- Middle Aged
- Myeloid-Lymphoid Leukemia Protein -- genetics
- Nuclear Proteins -- genetics
- Oncogene Proteins, Fusion -- genetics
- Real-Time Polymerase Chain Reaction
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.